{"id":"egb-761-tanakan","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Bleeding risk (minor)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"EGb 761 contains flavonoids and terpenoids that enhance microcirculation, increase oxygen and glucose utilization in tissues, and scavenge free radicals. It also modulates neurotransmitter function and reduces platelet aggregation, contributing to improved cognitive and vascular function.","oneSentence":"EGb 761 is a standardized Ginkgo biloba extract that improves blood flow and reduces oxidative stress in the brain and peripheral tissues.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:35:54.976Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Age-related cognitive decline and dementia"},{"name":"Peripheral arterial occlusive disease (claudication)"},{"name":"Tinnitus and vertigo"}]},"trialDetails":[{"nctId":"NCT07236645","phase":"PHASE2","title":"Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2025-11-20","conditions":"Non-proliferative Diabetic Retinopathy (NPDR)","enrollment":200},{"nctId":"NCT06583941","phase":"NA","title":"Effects of Indena's Virtiva® Plus Ginkgo Biloba Extract on Stress, and Cognitive Performance","status":"COMPLETED","sponsor":"Applied Science & Performance Institute","startDate":"2025-01-10","conditions":"Stress, Mood, Cognitive Change","enrollment":60},{"nctId":"NCT06309914","phase":"NA","title":"The Effects of Mirtoselect®, Virtiva®, and Enovita® on Cognitive Performance and Mood States","status":"COMPLETED","sponsor":"Applied Science & Performance Institute","startDate":"2024-02-21","conditions":"Mental Processes, Cognitive Change, Mood Change","enrollment":76},{"nctId":"NCT06403787","phase":"PHASE2, PHASE3","title":"Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment","status":"COMPLETED","sponsor":"University of Guadalajara","startDate":"2022-05-01","conditions":"Human Immunodeficiency Virus","enrollment":28},{"nctId":"NCT00276341","phase":"PHASE3","title":"Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis","status":"COMPLETED","sponsor":"Ipsen","startDate":"2003-08-26","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":47},{"nctId":"NCT04685005","phase":"NA","title":"\"WakeUp\" for Vigilance Following Lunch","status":"COMPLETED","sponsor":"Carmel Medical Center","startDate":"2018-11-01","conditions":"Fatigue","enrollment":30},{"nctId":"NCT05300594","phase":"NA","title":"Effect of Audistim® Day/Night on Hearing Comfort and Patient Quality of Life of Patients With Chronic Tinnitus.","status":"COMPLETED","sponsor":"CEN Biotech","startDate":"2022-03-01","conditions":"Tinnitus","enrollment":110},{"nctId":"NCT00500500","phase":"PHASE2","title":"Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease","status":"TERMINATED","sponsor":"Ipsen","startDate":"2005-07","conditions":"Alzheimer Disease","enrollment":40},{"nctId":"NCT05594355","phase":"PHASE4","title":"Effect of Treatment With EGb 761(r) on Blood Markers of Inflammation and Oxidative Stress in Patients With MCI","status":"UNKNOWN","sponsor":"Fundació ACE Institut Català de Neurociències Aplicades","startDate":"2021-04-16","conditions":"Mild Cognitive Impairment (MCI)","enrollment":100},{"nctId":"NCT04121728","phase":"NA","title":"Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba","status":"UNKNOWN","sponsor":"Jean-François Démonet","startDate":"2019-09-09","conditions":"Subjective Cognitive Decline, Cognitive Performance, Functional Capacity","enrollment":16},{"nctId":"NCT01637168","phase":"PHASE3","title":"Comparison of the Panax Ginseng + Associations to Ginkgo Biloba in the Treatment of Cognitive Function Disorders","status":"WITHDRAWN","sponsor":"EMS","startDate":"","conditions":"Memory Deficit","enrollment":""},{"nctId":"NCT00824512","phase":"PHASE2","title":"Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia","status":"COMPLETED","sponsor":"Ipsen","startDate":"2008-06","conditions":"Friedreich Ataxia","enrollment":22},{"nctId":"NCT02321475","phase":"","title":"EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders","status":"COMPLETED","sponsor":"Ipsen","startDate":"2014-06","conditions":"Cognitive Disorders","enrollment":54},{"nctId":"NCT03318276","phase":"PHASE3","title":"Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2017-02-20","conditions":"Peripheral Arterial Disease","enrollment":170},{"nctId":"NCT00814346","phase":"PHASE2","title":"Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions","status":"COMPLETED","sponsor":"Ipsen","startDate":"2008-10","conditions":"Alzheimer's Disease, Cognitive Impairment","enrollment":49},{"nctId":"NCT00276510","phase":"PHASE4","title":"A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints","status":"COMPLETED","sponsor":"Ipsen","startDate":"2002-02","conditions":"Memory Disorders, Age-Related, Retention Disorders, Cognitive","enrollment":2878},{"nctId":"NCT00276380","phase":"PHASE3","title":"A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke","status":"COMPLETED","sponsor":"Ipsen","startDate":"2003-02","conditions":"Stroke, Acute, Neurological Impairment","enrollment":204},{"nctId":"NCT03542721","phase":"PHASE4","title":"Effect of DA-5515 (Circulan® Soft Cap.) in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation","status":"UNKNOWN","sponsor":"Dong-A Pharmaceutical","startDate":"2018-01-17","conditions":"Fatigue Symptom","enrollment":204},{"nctId":"NCT00251238","phase":"PHASE2","title":"Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon","status":"COMPLETED","sponsor":"VSM Geneesmiddelen b.v.","startDate":"2005-11","conditions":"Raynaud Disease","enrollment":41},{"nctId":"NCT02298426","phase":"NA","title":"Body Constitution Classification Based Comprehensive Health Management Intervention on Obese Population","status":"COMPLETED","sponsor":"Hai-Jun Wang","startDate":"2014-04","conditions":"Overweight, Obesity","enrollment":1452},{"nctId":"NCT01046292","phase":"PHASE4","title":"Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2010-01","conditions":"Mild Cognitive Impairment","enrollment":50},{"nctId":"NCT01364311","phase":"NA","title":"Treatment of Dry Eye With Supplements","status":"WITHDRAWN","sponsor":"Medical University of Vienna","startDate":"2011-07","conditions":"Dry Eye Syndromes","enrollment":""},{"nctId":"NCT01672359","phase":"NA","title":"Evaluating Whole Foods Supplementation on Cognition","status":"COMPLETED","sponsor":"University of Miami","startDate":"2011-05","conditions":"Sub-optimal Cognitive Function, Sub-optimal Immune Function","enrollment":97}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":61,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"EGb 761® (Tanakan®)","genericName":"EGb 761® (Tanakan®)","companyName":"Ipsen","companyId":"ipsen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"EGb 761 is a standardized Ginkgo biloba extract that improves blood flow and reduces oxidative stress in the brain and peripheral tissues. Used for Age-related cognitive decline and dementia, Peripheral arterial occlusive disease (claudication), Tinnitus and vertigo.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}